Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers

Biotechnology Letters

Volumn 34, Issue 12, 2012, Pages 2183-2190

  Pan, XiaoPing ^a   Li, JianZhou ^a   Du, WeiBo ^a   Yu, XiaoPeng ^a   Zhu, ChunXia ^a   Yu, ChengBo ^a   Cao, HongCui ^a   Zhang, YiMin ^a   Chen, Yu ^a   Li, LanJuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bioartificial liver; Human hepatocytes; Immortalization; Large scale culture; Simian virus 40 large T antigen

Indexed keywords

BIOARTIFICIAL LIVER; CELL LINES; CELL SOURCES; CELLULAR FUNCTION; CYTOCHROME P450; FUNCTIONAL CHARACTERISTICS; GLUTAMINE SYNTHETASE; HEPATOCYTES; HUMAN HEPATOCYTES; IMMORTALIZATION; MRNA EXPRESSION; NUDE MICE; SHORT TANDEM REPEATS; SIMIAN VIRUS; WESTERN BLOTTING;

AMINO ACIDS; ANTIGENS; ARTIFICIAL ORGANS; CELL CULTURE; CELLS; TRANSCRIPTION; VIRUSES;

MOLECULAR BIOLOGY;

MESSENGER RNA; VIRUS RNA;

ANIMAL; ARTICLE; ARTIFICIAL LIVER; BIOSYNTHESIS; CELL LINE; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER CELL; MOUSE; NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; VIRUS CELL TRANSFORMATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL TRANSFORMATION, VIRAL; HEPATOCYTES; HUMANS; LIVER, ARTIFICIAL; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SIMIAN VIRUS 40; TRANSFECTION;

MUS MUSCULUS; SIMIAN VIRUS 40;

EID: 84868479394     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-012-1025-1     Document Type: Article

References (16)

1. Bader A, De Bartolo L, Haverich A (2000) High level benzodiazepine and ammonia clearance by flat membrane bioreactors with porcine liver cells. J Biotechnol 81: 95-105.
2. Bergheim I, Wolfgarten E, Bollschweiler E, Holscher AH, Bode C, Parlesak A (2007) Cytochrome P450 levels are altered in patients with esophageal squamous cell carcinoma. World J Gastroenterol 13: 997-1002.
3. Carpentier B, Gautier A, Legallais C (2009) Artificial and bioartificial liver devices: present and future. Gut 58: 1690-1702.
4. Choi S, Sainz B Jr, Corcoran P, Uprichard S, Jeong H (2009) Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 39: 205-217.
5. Ding YT, Shi XL (2011) Bioartificial liver devices: perspectives on the state of the art. Front Med 5: 15-19.
6. Enosawa S, Suzuki S, Kakefuda T, Amemiya H (1996) Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplant 5: S39-S40.
7. Enosawa S, Miyashita T, Suzuki S, Li XK, Tsunoda M, Amemiya H, Yamanaka M, Hiramatsu S, Tanimura N, Omasa Tetal (2000) Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver. Cell Transplant 9: 711-715.
8. Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, Miyazaki M, Cai J, Tanaka N, Fox IJ et al (2000) Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287: 1258-1262.
9. Lazaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, Foraker J, Rhim JA, Yeoh GC, Fausto N (2003) Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38: 1095-1106.
10. Li J, Li L, Yu H, Cao H, Gao C, Gong Y (2006) Growth and metabolism of human hepatocytes on biomodified collagen poly(lactic-co-glycolic acid) three-dimensional scaffold. ASAIO J 52: 321-327.
11. Mavri-Damelin D, Damelin LH, Eaton S, Rees M, Selden C, Hodgson HJ (2008) Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 99: 644-651.
12. Pan X, Du W, Yu X, Sheng G, Cao H, Yu C, Lv G, Huang H, Chen Y, Li J et al (2010) Establishment and characterization of immortalized porcine hepatocytes for the study of hepatocyte xenotransplantation. Transplant Proc 42: 1899-1906.
13. Poyck PP, van Wijk AC, van der Hoeven TV, de Waart DR, Chamuleau RA, van Gulik TM, Oude Elferink RP, Hoekstra R (2008) Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol 48: 266-275.
14. Qian Y, Lanjuan L, Jianrong H, Jun L, Hongcui C, Suzhen F, Xia Y, Shuhong Y (2003) Study of severe hepatitis treated with a hybrid artificial liver support system. Int J Artif Organs 26: 507-513.
15. Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, Okitsu T, Westerman KA, Kohara M, Reth Metal (2007) Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol 47: 74-82.
16. Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC (2011) Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. PLoS ONE 6: e26608.